Leonard E. Post - 01 Aug 2022 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Reporting relationship: Director
Issuer ticker: FLGT
Reported as of: 01 Aug 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Aug 2022, 17:44:13 UTC
Prior SEC filing: 17 Jun 2022
Next SEC filing: 01 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Paul Kim as Attorney-in-Fact

Key filing fact

Leonard E. Post filed Form 4 for Fulgent Genetics, Inc. (FLGT) on 03 Aug 2022.

Key facts

This page summarizes Leonard E. Post's Form 4 filing for Fulgent Genetics, Inc. (FLGT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Aug 2022, 17:44.

Change

Previous filing in this sequence was filed on 17 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FLGT transaction

Common Stock

Award

Transaction value: $0
Shares: +8,000
Change %
Price: $0.000000
Shares after: 8,000
Date: 01 Aug 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.